Nektar Therap to Release FY2025 Q2 Earnings on August 7 After-Market (EST), Forecast Revenue USD 9.416 M, EPS USD -3.0341

Brief Summary

Nektar Therapeutics is set to announce its Q2 2025 financial results on August 7, 2025, with market expectations of $9.42 million in revenue and an EPS of -$3.0341.

Impact of The News

The upcoming financial report of Nektar Therapeutics on August 7, 2025, is significant due to several key indicators:

1. Market Expectations:

• Revenue: Expected to be $9.42 million.
• EPS: Expected to be -$3.0341.

2. Previous Performance:

• In the last report dated May 8, 2023, the company reported an EPS of -$3.30, missing the analysts’ expectation of -$2.70 by $0.60 Market Beat.
• The company has a history of underperforming against market expectations.

3. Peer Comparison:

• Comparing to peers, companies like Apple and Meta have shown strong earnings surpassing market expectations significantly .

4. Stock Analysis:

• B. Riley upgraded the target price of Nektar Therapeutics from $60.00 to $85.00 and gave it a